Page 3 - Abhineet Kumar

Blow to Cipla; company loses court battle in drug-overcharging case

Company had received notices of demand aggregating to Rs 1,768 cr

Brookfield may emerge the largest investor this year

The Canadian fund announced investments worth $2.6 bn this month

Piramal aims to be among top 3 in OTC business

In the past two years, Piramal has made six acquisitions in the health care business, of which three are for the OTC business

Piramal acquires five brands for Rs 1,164 crore

Upfront payment of $155 mn to be made to Janssen Pharmaceutica for acquisition

Intas is the dark horse of Indian pharma sector

Low profile Chudgar family's value creation strategy tilts the Teva-asset sale deal in its favour

We are not averse to IPO, but after four-five years: Binish Chudgar

Interview with vice-chairman and managing director, Intas Pharmaceuticals

Intas buys Teva assets for Rs 5,100 cr

Ahmedabad-based firm beats domestic rival Aurobindo, global giants Mylan and Novartis

Mitsubishi backs Aurobindo, Intas for Teva asset bid

Teva is selling assets as part of a broader divestiture process to comply with the anti-trust regulations for its $40-bn acquisition of Allergan Plc's generics business

RIL may invest in mature start-ups to deploy Rs 5,000-cr fund

Mukesh Ambani-announced VC fund will promote start-ups on Jio's telecom network

We will acquire power assets worth $3.5 billion: Prashant Purker

Interview with MD & CEO, ICICI Venture Funds

Intas enters big league with $1-bn bid for Teva assets

The presence of PEs on the company's board has ensured our strategies are validated: Binish Hasmukh Chudgar

Earn right to grow, Mistry tells firms

Tata group chairman lays out road map

Soaring losses may queer Tata Tele's spectrum pitch

Accumulated sum Rs 31,500 crore in 2015-16

Swiss PE giant Partners Group eyes deals in health care

There is a dearth of good quality, well-run health care facilities in India; it is a steady business, so we like it: Manas Tandon

Tata, Nilekani, Kelkar to launch financial inclusion venture

The venture is applying to the Reserve Bank of India for approvals

NSE public offer may see largest PE exit

A bunch of these entities with investments of Rs 6,600 crore over a decade are eager to book returns

Call option volumes surge on Idea-Vodafone merger buzz

Before the denials came, the markets had already celebrated, share price of Idea in the cash segment surged and closed 6.7% higher on the BSE at Rs 100.80

Tata Sons seeks time to reply to UK court order

The move comes after Tata Sons' brass including chairman Cyrus Mistry and chairman emeritus Ratan Tata met NTT Docomo officials

KKR India's manufacturing bets pay off

This year, it made exits from Gland Pharma, Alliance Tire and Dalmia Cement

Aditya Birla Nuvo to merge with Grasim

Deal to create Rs 60,000-cr entity; financial services business to be listed after demerger